Search results
Results From The WOW.Com Content Network
Tafamidis, sold under the brand names Vyndaqel and Vyndamax, [5] is a medication used to delay disease progression in adults with certain forms of transthyretin amyloidosis. It can be used to treat both hereditary forms, familial amyloid cardiomyopathy and familial amyloid polyneuropathy , as well as wild-type transthyretin amyloidosis , which ...
In November 2021, Pfizer submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization for the co-packaged medication. [62] [63] [64] The authorization was granted in December 2021, for people 12 years of age or older who are infected with COVID‑19 and are at risk. [12] [17] [65]
Description Request to Pfizer for informed consent documents.pdf. English: In this letter user:bluerasberry requests information from Pfizer so that the information can be presented through Wikimedia projects. Particularly, this information would be about clinical trials. Date. 20 July 2014, 21:37:51.
May 13, 2024 at 4:22 PM. Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients. Pfizer Inc (NYSE: PFE) is looking to build on the success of its COVID-19 vaccine rollout by ...
Humedica and Pfizer Form Strategic Alliance BOSTON & NEW YORK--(BUSINESS WIRE)-- Humedica, Inc. and Pfizer Inc. (NYS: PFE) today announced a multi-year strategic alliance to jointly advance ...
Pfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for years longer than other drugs, according to new research published Friday.
The Patient Health Questionnaire ( PHQ) is a multiple-choice self-report inventory that is used as a screening and diagnostic tool for mental health disorders of depression, anxiety, alcohol, eating, and somatoform disorders. It is the self-report version of the Prim ary Care E valuation of M ental D isorders ( PRIME-MD ), a diagnostic tool ...
In December, I wrote about the drug maker Pfizer offering free prescription drugs to people who lost their jobs and health coverage in 2009. After that, I got an e-mail from a James Walker at APCO ...